We are live on
!
Find out more
ZAM
Zeal Asset Management Portfolio holdings
AUM
$39.4M
1-Year Est. Return
38.83%
This Fund
S&P 500
This Quarter
Est. Return
-33.17%
1 Year Est. Return
+38.83%
3 Year Est. Return
-26.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$76.7M
AUM Growth
-$89.6M
(-54%)
Cap. Flow
-$19.6M
Cap. Flow
% of AUM
-25.59%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONC
BeOne Medicines Ltd
ONC
|
+$30.1M |
| 2 |
Zai Lab
ZLAB
|
+$13.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HUTCHMED
HCM
|
+$32.8M |
| 2 |
NBP
NovaBridge Biosciences American Depositary Shares
NBP
|
+$30.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 92.9% |
| 2 | Technology | 5.11% |
| 3 | Real Estate | 1.99% |
Similar funds
BGDR
HCM
BEVI
MAM
NLG
KXA
SIP
AMC
Zeal Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Zeal Asset Management held 6 positions worth $76.7M, down 54% from $166M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Zeal Asset Management withdrew a net $19.6M in Q1 2022, reducing 2 holdings. Its largest reduction was HUTCHMED, cutting an estimated $32.8M.
By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 96% a quarter earlier, followed by Technology and Real Estate.
Against the trend, Zeal Asset Management added an estimated $30.1M to BeOne Medicines Ltd.
- Zeal Asset Management added most to BeOne Medicines Ltd in Q1 2022, an estimated $30.1M increase.
- Zeal Asset Management's biggest Q1 2022 reduction was HUTCHMED, cutting an estimated $32.8M.
- Zeal Asset Management's ten largest holdings make up 100% of its $76.7M portfolio in Q1 2022.
- Zeal Asset Management opened 0 new positions and closed 0 in Q1 2022.
- Zeal Asset Management's portfolio value fell 54% quarter-over-quarter to $76.7M.
Based on Zeal Asset Management's 13F filing for Q1 2022, filed 6 May 2022.